Results of a randomized controlled clinical trial are being published to report on the effects of weight-bearing versus non-weight-bearing exercise for people with diabetic peripheral neuropathy. Participants were recruited from...
read more →
A new drug therapy, nabilone, has been tested at University of Calgary's Hotchkiss Brain Institute. At the end of the study, patients reported less pain and an improvement in sleep and...
read more →
Dr. Charles E. Argoff, Albany (NY) Medical Center, discussed diabetic peripheral neuropathy at PAINWeek 2012. He provided instruction in how to recognize and treat DPN. Quality of life is heavily...
read more →
Julia Boyle, PhD., University of Surrey (UK), and colleagues conducted a study of Type 1 and Type 2 diabetics with chronic painful DPN taking common medications to treat DPN: amittryptiline...
read more →
Janssen Pharmaceuticals, Inc. announced the FDA has approved the supplemental New Drug Application for NUCYNTA ER extended-release tables for the management of neuropathic pain associated with diabetic peripheral neuropathy. NUCYNTA...
read more →
The American Chronic Pain Society joined with Pfizer to conduct a survey on the prevalence of symptoms of diabetic peripheral neuropathy in patients with diabetes. Their results show that nerve pain...
read more →
New study has been published showing the potential of stem cells providing relief to people suffering from painful diabetic peripheral neuropathy (DPN). Stem Cells Translational Medicine published the study on...
read more →
Researchers at the University of New South Wales have new reserach that may lead to new therapeutic approaches for treating patients with diabetic neuropathy, reported Professor Matthew Kiernan in Diabetes. They tested nerve...
read more →
A sytematic review of enhanced glucose control, studied at the University of Michigan and reported in The Cochrane Library, suggests that it is possible to prevent neuropathy by strict control of...
read more →
A new UK study, published in the American Journal of Respiratory and Critical Care Medicine shows that obstructive sleep apnea (OSA) is independently linked to diabetic peripheral neuropathy (DPN) in patients with Type 2 diabetes....
read more →
« Previous Page — Next Page »